Peptide Reference
Selank
Selank
A synthetic peptide developed in Russia with anxiolytic (anti-anxiety) and nootropic properties. A modified fragment of tuftsin with enhanced stability and CNS effects.
Status
approved
Category
cognitive
Typical cost
$35-90/vial (10mg)
Mechanism
Modulates expression of neurotrophic factors, enhances GABAergic neurotransmission, modulates enkephalin degradation, and affects serotonin metabolism. Provides anxiolytic effects without sedation or addiction potential.
Potential benefits
- Reduced anxiety
- Improved mood
- Enhanced cognitive function
- Better stress resilience
- No sedation
- Non-addictive
Reported side effects
- Mild headache
- Nasal irritation
- Slight drowsiness (rare)
Common dosing references
intranasal
100-300mcg · Daily
2-4 weeks
subcutaneous
200-500mcg · Daily
2-4 weeks
Research notes
Selank in generalized anxiety disorder
2008
Demonstrated anxiolytic effects comparable to benzodiazepines without sedation or withdrawal
Regulatory and sourcing notes
Approved in Russia for anxiety and cognitive disorders. Research chemical in US. Not FDA-approved.
Russian pharmaceutical or research chemical. Often combined with Semax for synergistic cognitive and anxiolytic effects.
Find peptide-aware clinics
Use location pages to compare clinics with peptide therapy signals and verify clinical oversight before treatment.
Related peptides